Chuen Wen Tan

750 total citations
31 papers, 366 citations indexed

About

Chuen Wen Tan is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chuen Wen Tan has authored 31 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 9 papers in Internal Medicine and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chuen Wen Tan's work include Venous Thromboembolism Diagnosis and Management (9 papers), Platelet Disorders and Treatments (7 papers) and COVID-19 Clinical Research Studies (5 papers). Chuen Wen Tan is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Platelet Disorders and Treatments (7 papers) and COVID-19 Clinical Research Studies (5 papers). Chuen Wen Tan collaborates with scholars based in Singapore, Australia and Malaysia. Chuen Wen Tan's co-authors include Vivien Chen, Caroline J. Reddel, Heng Joo Ng, Wan Hui Wong, Jenny G. Low, Ying Ying Chua, Lai Heng Lee, Bingwen Eugene Fan, Eng Soo Yap and Gek Hsiang Lim and has published in prestigious journals such as Blood, Scientific Reports and Cancers.

In The Last Decade

Chuen Wen Tan

29 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuen Wen Tan Singapore 9 139 101 83 68 66 31 366
Killian Donovan United Kingdom 8 81 0.6× 33 0.3× 65 0.8× 24 0.4× 57 0.9× 10 349
Tsunehiro Matsubara Japan 8 134 1.0× 65 0.6× 20 0.2× 20 0.3× 82 1.2× 13 379
Fakiha Siddiqui United States 9 50 0.4× 38 0.4× 43 0.5× 129 1.9× 20 0.3× 49 301
Anna Criniti Italy 9 76 0.5× 32 0.3× 38 0.5× 14 0.2× 50 0.8× 19 319
Gioacchino Galardo Italy 11 98 0.7× 44 0.4× 13 0.2× 16 0.2× 36 0.5× 47 343
Irene Mattioli Italy 10 87 0.6× 45 0.4× 45 0.5× 7 0.1× 53 0.8× 30 369
İsmail Hanta Türkiye 12 74 0.5× 33 0.3× 14 0.2× 18 0.3× 40 0.6× 46 360
Anis John Kadado United States 8 109 0.8× 49 0.5× 16 0.2× 8 0.1× 39 0.6× 22 411
Tali‐Anne Szwebel France 8 36 0.3× 67 0.7× 25 0.3× 8 0.1× 74 1.1× 14 521
Harshad Amin United States 13 97 0.7× 61 0.6× 25 0.3× 10 0.1× 25 0.4× 27 477

Countries citing papers authored by Chuen Wen Tan

Since Specialization
Citations

This map shows the geographic impact of Chuen Wen Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuen Wen Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuen Wen Tan more than expected).

Fields of papers citing papers by Chuen Wen Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuen Wen Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuen Wen Tan. The network helps show where Chuen Wen Tan may publish in the future.

Co-authorship network of co-authors of Chuen Wen Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Chuen Wen Tan. A scholar is included among the top collaborators of Chuen Wen Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuen Wen Tan. Chuen Wen Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Bingwen Eugene, Chuen Wen Tan, Benjamin Ong, et al.. (2025). Emerging Thrombolysis Technologies in Vascular Thrombosis. Journal of Clinical Medicine. 14(21). 7758–7758.
3.
Ang, Ai Leen, et al.. (2023). A randomized cross‐over study of cryopreserved platelets in prophylactic transfusions of thrombocytopenic patients. Transfusion. 63(9). 1649–1660. 1 indexed citations
4.
Wong, Wan Hui, et al.. (2023). Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study. Diagnostics. 13(14). 2447–2447. 2 indexed citations
5.
Ross, David M., Hai Liang, Shane Whittaker, et al.. (2023). Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombin. Scientific Reports. 13(1). 9172–9172. 6 indexed citations
6.
Fan, Bingwen Eugene, et al.. (2023). The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion. Thrombosis Journal. 21(1). 110–110. 7 indexed citations
7.
Tan, Guat Bee, Bernard P. Leung, Chuen Wen Tan, et al.. (2023). Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients. Seminars in Thrombosis and Hemostasis. 49(5). 561–564. 12 indexed citations
8.
Tan, Chuen Wen, et al.. (2022). A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin. Hematology. 27(1). 337–342. 3 indexed citations
9.
Lai, Kaitao, Jonathan D. Cheng, Shane Whittaker, et al.. (2021). Procoagulant Platelet Subpopulation As a Novel Predictive Biomarker of Poor Outcomes in Essential Thrombocythemia. Blood. 138(Supplement 1). 3622–3622.
10.
Tan, Chuen Wen, Jing Yuan Tan, Wan Hui Wong, et al.. (2021). Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities. Scientific Reports. 11(1). 1793–1793. 24 indexed citations
11.
Ong, Shin Yeu, et al.. (2021). Risk factors and predictors of treatment responses and complications in immune thrombocytopenia. Annals of Hematology. 100(3). 645–651. 2 indexed citations
12.
Tan, Chuen Wen, et al.. (2020). Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections. Scientific Reports. 10(1). 14186–14186. 8 indexed citations
13.
Tan, Jing Yuan, Chuen Wen Tan, Wan Hui Wong, et al.. (2020). Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses. Blood. 136(Supplement 1). 25–26. 1 indexed citations
14.
Tan, Chuen Wen, et al.. (2020). Critically ill COVID‐19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. American Journal of Hematology. 95(7). E156–E158. 81 indexed citations
15.
Reddel, Caroline J., Chuen Wen Tan, & Vivien Chen. (2019). Thrombin Generation and Cancer: Contributors and Consequences. Cancers. 11(1). 100–100. 72 indexed citations
16.
Tan, Chuen Wen, et al.. (2019). Flow Cytometry Assessment of Procoagulant Platelets Using a Dithiol-Reactive Probe. Methods in molecular biology. 1967. 305–321. 11 indexed citations
17.
Tan, Chuen Wen, et al.. (2017). The Influence of Race on Plasma Thrombin Generation In Healthy Subjects In Singapore. Clinical and Applied Thrombosis/Hemostasis. 24(7). 1144–1147. 4 indexed citations
18.
Wong, Wan Hui, Hwee‐Ling Koh, Lai Heng Lee, et al.. (2017). A randomized, double-blind, placebo- controlled study on the anti-haemostatic effects of Curcuma longa, Angelica sinensis and Panax ginseng. Phytomedicine. 32. 88–96. 18 indexed citations
19.
Lai, Yi Feng, et al.. (2017). Safety and efficacy of warfarin in patients with moderate thrombocytopenia. Thrombosis Research. 155. 53–57. 8 indexed citations
20.
Tan, Chuen Wen, Siew Ju See, Chee Kian Tham, & Ai Leen Ang. (2014). Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme. Annals of the Academy of Medicine Singapore. 43(6). 334–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026